CNR1 and attention deficit-hyperactivity disorder: Moreover, the therapeutic potential of ECS modulation—such as FAAH inhibitors to boost AEA/OEA/PEA or CB1 agonists to normalize 2-AG—warrants exploration, given anecdotal reports of cannabinoid benefits in ADHD symptom management (47).